Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2014

Open Access 01-12-2014 | Research

Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study

Authors: Isabel Sánchez-Guiu, Ana I Antón, José Padilla, Francisco Velasco, José F Lucia, Miguel Lozano, Ana Rosa Cid, Teresa Sevivas, María F Lopez-Fernandez, Vicente Vicente, Consuelo González-Manchón, José Rivera, María L Lozano

Published in: Orphanet Journal of Rare Diseases | Issue 1/2014

Login to get access

Abstract

Background

The diagnostic evaluation of inherited platelet disorders (IPDs) is complicated and time-consuming, resulting in a relevant number of undiagnosed and incorrectly classified patients. In order to evaluate the spectrum of IPDs in individuals with clinical suspicion of these disorders, and to provide a diagnostic tool to centers not having access to specific platelets studies, we established the project “Functional and Molecular Characterization of Patients with Inherited Platelet Disorders” under the scientific sponsorship of the Spanish Society of Thrombosis and Haemostasis.

Patients/methods

Subjects were patients from a prospective cohort of individuals referred for clinical suspicion of IPDs as well as healthy controls. Functional studies included light transmission aggregation, flow cytometry, and when indicated, Western-blot analysis of platelet glycoproteins, and clot retraction analysis. Genetic analysis was mainly performed by sequencing of coding regions and proximal regulatory regions of the genes of interest.

Results

Of the 70 cases referred for study, we functionally and molecularly characterized 12 patients with Glanzmann Thrombasthenia, 8 patients with Bernard Soulier syndrome, and 8 with other forms of IPDs. Twelve novel mutations were identified among these patients. The systematic study of patients revealed that almost one-third of patients had been previously misdiagnosed.

Conclusions

Our study provides a global picture of the current limitations and access to the diagnosis of IPDs, identifies and confirms new genetic variants that cause these disorders, and emphasizes the need of creating reference centers that can help health care providers in the recognition of these defects.
Literature
1.
go back to reference Quiroga T, Goycoolea M, Panes O, Aranda E, Martinez C, Belmont S, Munoz B, Zuniga P, Pereira J, Mezzano D: High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica. 2007, 92: 357-365. 10.3324/haematol.10816.CrossRefPubMed Quiroga T, Goycoolea M, Panes O, Aranda E, Martinez C, Belmont S, Munoz B, Zuniga P, Pereira J, Mezzano D: High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica. 2007, 92: 357-365. 10.3324/haematol.10816.CrossRefPubMed
2.
go back to reference Quiroga T, Goycoolea M, Matus V, Zuniga P, Martinez C, Garrido M, Aranda E, Leighton F, Panes O, Pereira J, Mezzano D: Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol. 2009, 147: 729-736. 10.1111/j.1365-2141.2009.07890.x.CrossRefPubMed Quiroga T, Goycoolea M, Matus V, Zuniga P, Martinez C, Garrido M, Aranda E, Leighton F, Panes O, Pereira J, Mezzano D: Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol. 2009, 147: 729-736. 10.1111/j.1365-2141.2009.07890.x.CrossRefPubMed
3.
go back to reference Lambert MP: What to do when you suspect an inherited platelet disorder. Hematology Am Soc Hematol Educ Program. 2011, 2011: 377-383. 10.1182/asheducation-2011.1.377.CrossRefPubMed Lambert MP: What to do when you suspect an inherited platelet disorder. Hematology Am Soc Hematol Educ Program. 2011, 2011: 377-383. 10.1182/asheducation-2011.1.377.CrossRefPubMed
4.
go back to reference Rao AK: Inherited platelet function disorders: overview and disorders of granules, secretion, and signal transduction. Hematol Oncol Clin North Am. 2013, 27: 585-611. 10.1016/j.hoc.2013.02.005.CrossRefPubMed Rao AK: Inherited platelet function disorders: overview and disorders of granules, secretion, and signal transduction. Hematol Oncol Clin North Am. 2013, 27: 585-611. 10.1016/j.hoc.2013.02.005.CrossRefPubMed
5.
go back to reference Balduini CL, Cattaneo M, Fabris F, Gresele P, Iolascon A, Pulcinelli FM, Savoia A, Italian Gruppo di Studio delle P: Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica. 2003, 88: 582-592.PubMed Balduini CL, Cattaneo M, Fabris F, Gresele P, Iolascon A, Pulcinelli FM, Savoia A, Italian Gruppo di Studio delle P: Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica. 2003, 88: 582-592.PubMed
6.
go back to reference Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, Machin S: Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol. 2011, 155: 30-44. 10.1111/j.1365-2141.2011.08793.x.CrossRefPubMed Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, Machin S: Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol. 2011, 155: 30-44. 10.1111/j.1365-2141.2011.08793.x.CrossRefPubMed
7.
go back to reference Dawood BB, Lowe GC, Lordkipanidze M, Bem D, Daly ME, Makris M, Mumford A, Wilde JT, Watson SP: Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood. 2012, 120: 5041-5049. 10.1182/blood-2012-07-444281.CrossRefPubMedPubMedCentral Dawood BB, Lowe GC, Lordkipanidze M, Bem D, Daly ME, Makris M, Mumford A, Wilde JT, Watson SP: Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel. Blood. 2012, 120: 5041-5049. 10.1182/blood-2012-07-444281.CrossRefPubMedPubMedCentral
8.
go back to reference Glembotsky AC, Marta RF, Pecci A, De Rocco D, Gnan C, Espasandin YR, Goette NP, Negro F, Noris P, Savoia A, Balduini CL, Molinas FC, Heller PG: International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing country. J Thromb Haemost. 2012, 10: 1653-1661. 10.1111/j.1538-7836.2012.04805.x.CrossRefPubMed Glembotsky AC, Marta RF, Pecci A, De Rocco D, Gnan C, Espasandin YR, Goette NP, Negro F, Noris P, Savoia A, Balduini CL, Molinas FC, Heller PG: International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing country. J Thromb Haemost. 2012, 10: 1653-1661. 10.1111/j.1538-7836.2012.04805.x.CrossRefPubMed
9.
go back to reference Dovlatova N, Lordkipanidze M, Lowe GC, Dawood B, May J, Heptinstall S, Watson SP, Fox SC: Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders. J Thromb Haemost. 2014, 12: 660-665.CrossRefPubMedPubMedCentral Dovlatova N, Lordkipanidze M, Lowe GC, Dawood B, May J, Heptinstall S, Watson SP, Fox SC: Evaluation of a whole blood remote platelet function test for the diagnosis of mild bleeding disorders. J Thromb Haemost. 2014, 12: 660-665.CrossRefPubMedPubMedCentral
10.
go back to reference Pereira J, Quiroga T, Mezzano D: Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible. Semin Thromb Hemost. 2008, 34: 654-662. 10.1055/s-0028-1104544.CrossRefPubMed Pereira J, Quiroga T, Mezzano D: Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible. Semin Thromb Hemost. 2008, 34: 654-662. 10.1055/s-0028-1104544.CrossRefPubMed
11.
go back to reference Lambert MP, Poncz M: They’re not your daddy’s inherited platelet disorders anymore. J Thromb Haemost. 2013, 11: 2037-2038. 10.1111/jth.12405.CrossRefPubMed Lambert MP, Poncz M: They’re not your daddy’s inherited platelet disorders anymore. J Thromb Haemost. 2013, 11: 2037-2038. 10.1111/jth.12405.CrossRefPubMed
12.
go back to reference Daly ME, Leo VC, Lowe GC, Watson SP, Morgan NV: What is the role of genetic testing in the investigation of patients with suspected platelet function disorders? Br J Haematol 2014, 165:193–203., Daly ME, Leo VC, Lowe GC, Watson SP, Morgan NV: What is the role of genetic testing in the investigation of patients with suspected platelet function disorders? Br J Haematol 2014, 165:193–203.,
13.
go back to reference Drachman JG: Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood. 2004, 103: 390-398. 10.1182/blood-2003-05-1742.CrossRefPubMed Drachman JG: Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood. 2004, 103: 390-398. 10.1182/blood-2003-05-1742.CrossRefPubMed
14.
go back to reference Andrews RK, Berndt MC: Bernard-Soulier syndrome: an update. Semin Thromb Hemost. 2013, 39: 656-662. 10.1055/s-0033-1353390.CrossRefPubMed Andrews RK, Berndt MC: Bernard-Soulier syndrome: an update. Semin Thromb Hemost. 2013, 39: 656-662. 10.1055/s-0033-1353390.CrossRefPubMed
15.
go back to reference Nurden AT, Pillois X, Wilcox DA: Glanzmann thrombasthenia: state of the art and future directions. Semin Thromb Hemost. 2013, 39: 642-655. 10.1055/s-0033-1353393.CrossRefPubMedPubMedCentral Nurden AT, Pillois X, Wilcox DA: Glanzmann thrombasthenia: state of the art and future directions. Semin Thromb Hemost. 2013, 39: 642-655. 10.1055/s-0033-1353393.CrossRefPubMedPubMedCentral
16.
go back to reference de Moerloose P, Levrat E, Fontana P, Boehlen F: Diagnosis of mild bleeding disorders. Swiss Med Wkly. 2009, 139: 327-332.PubMed de Moerloose P, Levrat E, Fontana P, Boehlen F: Diagnosis of mild bleeding disorders. Swiss Med Wkly. 2009, 139: 327-332.PubMed
17.
go back to reference Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A: The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost. 2005, 3: 2619-2626. 10.1111/j.1538-7836.2005.01663.x.CrossRefPubMed Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A: The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost. 2005, 3: 2619-2626. 10.1111/j.1538-7836.2005.01663.x.CrossRefPubMed
18.
go back to reference Bolton-Maggs PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, Minford A, Mumford AD, Parapia LA, Perry DJ, Watson SP, Wilde JT, Williams MD, UKHCDO: A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol. 2006, 135: 603-633. 10.1111/j.1365-2141.2006.06343.x.CrossRefPubMed Bolton-Maggs PH, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, Minford A, Mumford AD, Parapia LA, Perry DJ, Watson SP, Wilde JT, Williams MD, UKHCDO: A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol. 2006, 135: 603-633. 10.1111/j.1365-2141.2006.06343.x.CrossRefPubMed
19.
go back to reference Tello-Montoliu A, Jover E, Marin F, Bernal A, Lozano ML, Sanchez-Vega B, Pastor FJ, Hurtado JA, Valdes M, Vicente V, Rivera J: Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2012, 65: 219-226. 10.1016/j.recesp.2011.07.013.CrossRef Tello-Montoliu A, Jover E, Marin F, Bernal A, Lozano ML, Sanchez-Vega B, Pastor FJ, Hurtado JA, Valdes M, Vicente V, Rivera J: Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome. Rev Esp Cardiol (Engl Ed). 2012, 65: 219-226. 10.1016/j.recesp.2011.07.013.CrossRef
20.
go back to reference Cattaneo M, Lecchi A, Zighetti ML, Lussana F: Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica. 2007, 92: 694-697. 10.3324/haematol.10999.CrossRefPubMed Cattaneo M, Lecchi A, Zighetti ML, Lussana F: Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica. 2007, 92: 694-697. 10.3324/haematol.10999.CrossRefPubMed
21.
go back to reference Ward CM, Kestin AS, Newman PJ: A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen. Blood. 2000, 96: 161-169.PubMed Ward CM, Kestin AS, Newman PJ: A Leu262Pro mutation in the integrin beta(3) subunit results in an alpha(IIb)-beta(3) complex that binds fibrin but not fibrinogen. Blood. 2000, 96: 161-169.PubMed
22.
go back to reference Othman M, Kaur H, Emsley J: Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defect. Semin Thromb Hemost. 2013, 39: 663-673. 10.1055/s-0033-1353442.CrossRefPubMed Othman M, Kaur H, Emsley J: Platelet-type von Willebrand disease: new insights into the molecular pathophysiology of a unique platelet defect. Semin Thromb Hemost. 2013, 39: 663-673. 10.1055/s-0033-1353442.CrossRefPubMed
23.
go back to reference Germeshausen M, Ballmaier M, Welte K: MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Hum Mutat. 2006, 27: 296-10.1002/humu.9415.CrossRefPubMed Germeshausen M, Ballmaier M, Welte K: MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Hum Mutat. 2006, 27: 296-10.1002/humu.9415.CrossRefPubMed
24.
go back to reference Pippucci T, Savoia A, Perrotta S, Pujol-Moix N, Noris P, Castegnaro G, Pecci A, Gnan C, Punzo F, Marconi C, Gherardi S, Loffredo G, De Rocco D, Scianguetta S, Barozzi S, Magini P, Bozzi V, Dezzani L, Di Stazio M, Ferraro M, Perini G, Seri M, Balduini CL: Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am J Hum Genet. 2011, 88: 115-120. 10.1016/j.ajhg.2010.12.006.CrossRefPubMedPubMedCentral Pippucci T, Savoia A, Perrotta S, Pujol-Moix N, Noris P, Castegnaro G, Pecci A, Gnan C, Punzo F, Marconi C, Gherardi S, Loffredo G, De Rocco D, Scianguetta S, Barozzi S, Magini P, Bozzi V, Dezzani L, Di Stazio M, Ferraro M, Perini G, Seri M, Balduini CL: Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2. Am J Hum Genet. 2011, 88: 115-120. 10.1016/j.ajhg.2010.12.006.CrossRefPubMedPubMedCentral
25.
go back to reference Rubio-Camarillo M, Gomez-Lopez G, Fernandez JM, Valencia A, Pisano DG: RUbioSeq: a suite of parallelized pipelines to automate exome variation and bisulfite-seq analyses. Bioinformatics. 2013, 29: 1687-1689. 10.1093/bioinformatics/btt203.CrossRefPubMedPubMedCentral Rubio-Camarillo M, Gomez-Lopez G, Fernandez JM, Valencia A, Pisano DG: RUbioSeq: a suite of parallelized pipelines to automate exome variation and bisulfite-seq analyses. Bioinformatics. 2013, 29: 1687-1689. 10.1093/bioinformatics/btt203.CrossRefPubMedPubMedCentral
26.
go back to reference Grimaldi CM, Chen F, Wu C, Weiss HJ, Coller BS, French DL: Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa. Blood. 1998, 91: 1562-1571.PubMed Grimaldi CM, Chen F, Wu C, Weiss HJ, Coller BS, French DL: Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa. Blood. 1998, 91: 1562-1571.PubMed
27.
go back to reference Gonzalez-Manchon C, Fernandez-Pinel M, Arias-Salgado EG, Ferrer M, Alvarez MV, Garcia-Munoz S, Ayuso MS, Parrilla R: Molecular genetic analysis of a compound heterozygote for the glycoprotein (GP) IIb gene associated with Glanzmann’s thrombasthenia: disruption of the 674-687 disulfide bridge in GPIIb prevents surface exposure of GPIIb-IIIa complexes. Blood. 1999, 93: 866-875.PubMed Gonzalez-Manchon C, Fernandez-Pinel M, Arias-Salgado EG, Ferrer M, Alvarez MV, Garcia-Munoz S, Ayuso MS, Parrilla R: Molecular genetic analysis of a compound heterozygote for the glycoprotein (GP) IIb gene associated with Glanzmann’s thrombasthenia: disruption of the 674-687 disulfide bridge in GPIIb prevents surface exposure of GPIIb-IIIa complexes. Blood. 1999, 93: 866-875.PubMed
28.
go back to reference D’Andrea G, Colaizzo D, Vecchione G, Grandone E, Di Minno G, Margaglione M: Glanzmann’s thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost. 2002, 87: 1034-1042.PubMed D’Andrea G, Colaizzo D, Vecchione G, Grandone E, Di Minno G, Margaglione M: Glanzmann’s thrombasthenia: identification of 19 new mutations in 30 patients. Thromb Haemost. 2002, 87: 1034-1042.PubMed
29.
go back to reference Nurden AT, Ruan J, Pasquet JM, Gauthier B, Combrie R, Kunicki T, Nurden P: A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia. Platelets. 2002, 13: 101-111. 10.1080/09537100220122466.CrossRefPubMed Nurden AT, Ruan J, Pasquet JM, Gauthier B, Combrie R, Kunicki T, Nurden P: A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia. Platelets. 2002, 13: 101-111. 10.1080/09537100220122466.CrossRefPubMed
30.
go back to reference Gonzalez-Manchon C, Butta N, Larrucea S, Arias-Salgado EG, Alonso S, Lopez A, Parrilla R: A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors. Thromb Haemost. 2004, 92: 1377-1386.PubMed Gonzalez-Manchon C, Butta N, Larrucea S, Arias-Salgado EG, Alonso S, Lopez A, Parrilla R: A variant thrombasthenic phenotype associated with compound heterozygosity of integrin beta3-subunit: (Met124Val)beta3 alters the subunit dimerization rendering a decreased number of constitutive active alphaIIbbeta3 receptors. Thromb Haemost. 2004, 92: 1377-1386.PubMed
31.
go back to reference Nurden AT, Breillat C, Jacquelin B, Combrie R, Freedman J, Blanchette VS, Schmugge M, Rand ML: Triple heterozygosity in the integrin alphaIIb subunit in a patient with Glanzmann’s thrombasthenia. J Thromb Haemost. 2004, 2: 813-819. 10.1046/j.1538-7836.2004.00711.x.CrossRefPubMed Nurden AT, Breillat C, Jacquelin B, Combrie R, Freedman J, Blanchette VS, Schmugge M, Rand ML: Triple heterozygosity in the integrin alphaIIb subunit in a patient with Glanzmann’s thrombasthenia. J Thromb Haemost. 2004, 2: 813-819. 10.1046/j.1538-7836.2004.00711.x.CrossRefPubMed
32.
go back to reference Jallu V, Dusseaux M, Panzer S, Torchet MF, Hezard N, Goudemand J, de Brevern AG, Kaplan C: AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function. Hum Mutat. 2010, 31: 237-246. 10.1002/humu.21179.CrossRefPubMed Jallu V, Dusseaux M, Panzer S, Torchet MF, Hezard N, Goudemand J, de Brevern AG, Kaplan C: AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function. Hum Mutat. 2010, 31: 237-246. 10.1002/humu.21179.CrossRefPubMed
33.
go back to reference Wright SD, Michaelides K, Johnson DJ, West NC, Tuddenham EG: Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome. Blood. 1993, 81: 2339-2347.PubMed Wright SD, Michaelides K, Johnson DJ, West NC, Tuddenham EG: Double heterozygosity for mutations in the platelet glycoprotein IX gene in three siblings with Bernard-Soulier syndrome. Blood. 1993, 81: 2339-2347.PubMed
34.
go back to reference Simsek S, Noris P, Lozano M, Pico M, von dem Borne AE, Ribera A, Gallardo D: Cys209 Ser mutation in the platelet membrane glycoprotein Ib alpha gene is associated with Bernard-Soulier syndrome. Br J Haematol. 1994, 88: 839-844. 10.1111/j.1365-2141.1994.tb05125.x.CrossRefPubMed Simsek S, Noris P, Lozano M, Pico M, von dem Borne AE, Ribera A, Gallardo D: Cys209 Ser mutation in the platelet membrane glycoprotein Ib alpha gene is associated with Bernard-Soulier syndrome. Br J Haematol. 1994, 88: 839-844. 10.1111/j.1365-2141.1994.tb05125.x.CrossRefPubMed
35.
go back to reference Noris P, Simsek S, Stibbe J, von dem Borne AE: A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. Br J Haematol. 1997, 97: 312-320. 10.1046/j.1365-2141.1997.582706.x.CrossRefPubMed Noris P, Simsek S, Stibbe J, von dem Borne AE: A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. Br J Haematol. 1997, 97: 312-320. 10.1046/j.1365-2141.1997.582706.x.CrossRefPubMed
36.
go back to reference Liang HP, Morel-Kopp MC, Clemetson JM, Clemetson KJ, Kekomaki R, Kroll H, Michaelides K, Tuddenham EG, Vanhoorelbeke K, Ward CM: A common ancestral glycoprotein (GP) 9 1828A > G (Asn45Ser) gene mutation occurring in European families from Australia and Northern Europe with Bernard-Soulier Syndrome (BSS). Thromb Haemost. 2005, 94: 599-605.PubMed Liang HP, Morel-Kopp MC, Clemetson JM, Clemetson KJ, Kekomaki R, Kroll H, Michaelides K, Tuddenham EG, Vanhoorelbeke K, Ward CM: A common ancestral glycoprotein (GP) 9 1828A > G (Asn45Ser) gene mutation occurring in European families from Australia and Northern Europe with Bernard-Soulier Syndrome (BSS). Thromb Haemost. 2005, 94: 599-605.PubMed
37.
go back to reference Savoia A, Balduini CL, Savino M, Noris P, Del Vecchio M, Perrotta S, Belletti S, Poggi, Iolascon A: Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood 2001, 97:1330–1335., Savoia A, Balduini CL, Savino M, Noris P, Del Vecchio M, Perrotta S, Belletti S, Poggi, Iolascon A: Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood 2001, 97:1330–1335.,
38.
go back to reference Miller JL, Lyle VA, Cunningham D: Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ib alpha leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood. 1992, 79: 439-446.PubMed Miller JL, Lyle VA, Cunningham D: Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ib alpha leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood. 1992, 79: 439-446.PubMed
39.
go back to reference Kunishima S, Imai T, Hamaguchi M, Saito H: Novel heterozygous missense mutation in the second leucine rich repeat of GPIbalpha affects GPIb/IX/V expression and results in macrothrombocytopenia in a patient initially misdiagnosed with idiopathic thrombocytopenic purpura. Eur J Haematol. 2006, 76: 348-355. 10.1111/j.1600-0609.2005.00612.x.CrossRefPubMed Kunishima S, Imai T, Hamaguchi M, Saito H: Novel heterozygous missense mutation in the second leucine rich repeat of GPIbalpha affects GPIb/IX/V expression and results in macrothrombocytopenia in a patient initially misdiagnosed with idiopathic thrombocytopenic purpura. Eur J Haematol. 2006, 76: 348-355. 10.1111/j.1600-0609.2005.00612.x.CrossRefPubMed
40.
go back to reference Vettore S, Scandellari R, Moro S, Lombardi AM, Scapin M, Randi ML, Fabris F: Novel point mutation in a leucine-rich repeat of the GPIbalpha chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families: the N41H variant. Haematologica. 2008, 93: 1743-1747. 10.3324/haematol.12830.CrossRefPubMed Vettore S, Scandellari R, Moro S, Lombardi AM, Scapin M, Randi ML, Fabris F: Novel point mutation in a leucine-rich repeat of the GPIbalpha chain of the platelet von Willebrand factor receptor, GPIb/IX/V, resulting in an inherited dominant form of Bernard-Soulier syndrome affecting two unrelated families: the N41H variant. Haematologica. 2008, 93: 1743-1747. 10.3324/haematol.12830.CrossRefPubMed
41.
go back to reference Savoia A, Pastore A, De Rocco D, Civaschi E, Di Stazio M, Bottega R, Melazzini F, Bozzi V, Pecci A, Magrin S, Balduini CL, Noris P: Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations. Haematologica. 2011, 96: 417-423. 10.3324/haematol.2010.032631.CrossRefPubMedPubMedCentral Savoia A, Pastore A, De Rocco D, Civaschi E, Di Stazio M, Bottega R, Melazzini F, Bozzi V, Pecci A, Magrin S, Balduini CL, Noris P: Clinical and genetic aspects of Bernard-Soulier syndrome: searching for genotype/phenotype correlations. Haematologica. 2011, 96: 417-423. 10.3324/haematol.2010.032631.CrossRefPubMedPubMedCentral
42.
go back to reference Sanchez-Guiu I, Anton AI, Garcia-Barbera N, Navarro-Fernandez J, Martinez C, Fuster JL, Couselo JM, Ortuno FJ, Vicente V, Rivera J, Lozano ML: Chediak-Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype. Eur J Haematol. 2014, 92: 49-58. 10.1111/ejh.12203.CrossRefPubMed Sanchez-Guiu I, Anton AI, Garcia-Barbera N, Navarro-Fernandez J, Martinez C, Fuster JL, Couselo JM, Ortuno FJ, Vicente V, Rivera J, Lozano ML: Chediak-Higashi syndrome: description of two novel homozygous missense mutations causing divergent clinical phenotype. Eur J Haematol. 2014, 92: 49-58. 10.1111/ejh.12203.CrossRefPubMed
43.
go back to reference Sanchez-Guiu I, Torregrosa JM, Velasco F, Anton AI, Lozano ML, Vicente V, Rivera J: Hermansky-Pudlak syndrome. Overview of clinical and molecular features and case report of a new HPS-1 variant. Hamostaseologie 2014, 34:301–309., Sanchez-Guiu I, Torregrosa JM, Velasco F, Anton AI, Lozano ML, Vicente V, Rivera J: Hermansky-Pudlak syndrome. Overview of clinical and molecular features and case report of a new HPS-1 variant. Hamostaseologie 2014, 34:301–309.,
44.
go back to reference Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, Ghiggeri GM, Ravazzolo R, Savino M, Del Vecchio M, d'Apolito M, Iolascon A, Zelante LL, Savoia A, Balduini CL, Noris P, Magrini U, Belletti S, Heath KE, Babcock M, Glucksman MJ, Aliprandis E, Bizzaro N, Desnick RJ, Martignetti JA: Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner syndrome sonsortium. Nat Genet. 2000, 26: 103-105. 10.1038/79063.CrossRefPubMed Seri M, Cusano R, Gangarossa S, Caridi G, Bordo D, Lo Nigro C, Ghiggeri GM, Ravazzolo R, Savino M, Del Vecchio M, d'Apolito M, Iolascon A, Zelante LL, Savoia A, Balduini CL, Noris P, Magrini U, Belletti S, Heath KE, Babcock M, Glucksman MJ, Aliprandis E, Bizzaro N, Desnick RJ, Martignetti JA: Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner syndrome sonsortium. Nat Genet. 2000, 26: 103-105. 10.1038/79063.CrossRefPubMed
45.
go back to reference Saposnik B, Binard S, Fenneteau O, Nurden A, Nurden P, Hurtaud-Roux M-F, Schlegel N, on behalf of the French MYHn: Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related Disorders. Mol Genet Genomic Med 2014, 2:297–312., Saposnik B, Binard S, Fenneteau O, Nurden A, Nurden P, Hurtaud-Roux M-F, Schlegel N, on behalf of the French MYHn: Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related Disorders. Mol Genet Genomic Med 2014, 2:297–312.,
46.
go back to reference Gresele P, Harrison P, Bury L, Falcinelli E, Gachet C, Hayward CP, Kenny D, Mezzano D, Mumford AD, Nugent D, Nurden AT, Orsini S, Cattaneo M: Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost 2014, 12:1562–1569., Gresele P, Harrison P, Bury L, Falcinelli E, Gachet C, Hayward CP, Kenny D, Mezzano D, Mumford AD, Nugent D, Nurden AT, Orsini S, Cattaneo M: Diagnosis of suspected inherited platelet function disorders: results of a worldwide survey. J Thromb Haemost 2014, 12:1562–1569.,
47.
go back to reference Cattaneo M, Hayward CP, Moffat KA, Pugliano MT, Liu Y, Michelson AD: Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009, 7:1029., Cattaneo M, Hayward CP, Moffat KA, Pugliano MT, Liu Y, Michelson AD: Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009, 7:1029.,
48.
go back to reference Jennings I, Woods TA, Kitchen S, Walker ID: Platelet function testing: practice among UK national external quality assessment scheme for blood coagulation participants, 2006. J Clin Pathol. 2008, 61: 950-954. 10.1136/jcp.2008.057174.CrossRefPubMed Jennings I, Woods TA, Kitchen S, Walker ID: Platelet function testing: practice among UK national external quality assessment scheme for blood coagulation participants, 2006. J Clin Pathol. 2008, 61: 950-954. 10.1136/jcp.2008.057174.CrossRefPubMed
49.
go back to reference Nurden P, Dreyfus M, Favier R, Negrier C, Schlegel N, Sie P, Nurden A: Reference center for platelet diseases. Arch Pediatr. 2007, 14: 679-682. 10.1016/j.arcped.2007.02.076.CrossRefPubMed Nurden P, Dreyfus M, Favier R, Negrier C, Schlegel N, Sie P, Nurden A: Reference center for platelet diseases. Arch Pediatr. 2007, 14: 679-682. 10.1016/j.arcped.2007.02.076.CrossRefPubMed
50.
go back to reference George JN, Caen JP, Nurden AT: Glanzmann’s thrombasthenia: the spectrum of clinical disease. Blood. 1990, 75: 1383-1395.PubMed George JN, Caen JP, Nurden AT: Glanzmann’s thrombasthenia: the spectrum of clinical disease. Blood. 1990, 75: 1383-1395.PubMed
51.
go back to reference Kannan M, Ahmad F, Yadav BK, Kumar R, Choudhry VP, Saxena R: Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia. J Thromb Haemost. 2009, 7: 1878-1885. 10.1111/j.1538-7836.2009.03579.x.CrossRefPubMed Kannan M, Ahmad F, Yadav BK, Kumar R, Choudhry VP, Saxena R: Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia. J Thromb Haemost. 2009, 7: 1878-1885. 10.1111/j.1538-7836.2009.03579.x.CrossRefPubMed
52.
go back to reference Vinciguerra C, Bordet JC, Beaune G, Grenier C, Dechavanne M, Negrier C: Description of 10 new mutations in platelet glycoprotein IIb (alphaIIb) and glycoprotein IIIa (beta3) genes. Platelets. 2001, 12: 486-495. 10.1080/095371001317126383.CrossRefPubMed Vinciguerra C, Bordet JC, Beaune G, Grenier C, Dechavanne M, Negrier C: Description of 10 new mutations in platelet glycoprotein IIb (alphaIIb) and glycoprotein IIIa (beta3) genes. Platelets. 2001, 12: 486-495. 10.1080/095371001317126383.CrossRefPubMed
53.
go back to reference Savoia A, Kunishima S, De Rocco D, Zieger B, Rand ML, Pujol-Moix N, Caliskan U, Tokgoz U, Pecci A, Noris P, Srivastava A, Ward C, Morel-Kopp MC, Alessi MC, Bellucci S, Beurrier P, de Maistre E, Favier R, Hézard N, Hurtaud-Roux MF, Latger-Cannard V, Lavenu-Bombled C, Proulle V, Meunier S, Négrier C, Nurden A, Randrianaivo H, Fabris F, Platokouki H, Rosenberg N, et al: Spectrum of the mutations in Bernard-Soulier syndrome. Hum Mutat. 2014, 35: 1033-1045. 10.1002/humu.22607.CrossRefPubMed Savoia A, Kunishima S, De Rocco D, Zieger B, Rand ML, Pujol-Moix N, Caliskan U, Tokgoz U, Pecci A, Noris P, Srivastava A, Ward C, Morel-Kopp MC, Alessi MC, Bellucci S, Beurrier P, de Maistre E, Favier R, Hézard N, Hurtaud-Roux MF, Latger-Cannard V, Lavenu-Bombled C, Proulle V, Meunier S, Négrier C, Nurden A, Randrianaivo H, Fabris F, Platokouki H, Rosenberg N, et al: Spectrum of the mutations in Bernard-Soulier syndrome. Hum Mutat. 2014, 35: 1033-1045. 10.1002/humu.22607.CrossRefPubMed
54.
go back to reference Carmona-Rivera C, Hess RA, O’Brien K, Golas G, Tsilou E, White JG, Gahl WA, Huizing M: Novel mutations in the HPS1 gene among Puerto Rican patients. Clin Genet. 2011, 79: 561-567. 10.1111/j.1399-0004.2010.01491.x.CrossRefPubMed Carmona-Rivera C, Hess RA, O’Brien K, Golas G, Tsilou E, White JG, Gahl WA, Huizing M: Novel mutations in the HPS1 gene among Puerto Rican patients. Clin Genet. 2011, 79: 561-567. 10.1111/j.1399-0004.2010.01491.x.CrossRefPubMed
Metadata
Title
Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study
Authors
Isabel Sánchez-Guiu
Ana I Antón
José Padilla
Francisco Velasco
José F Lucia
Miguel Lozano
Ana Rosa Cid
Teresa Sevivas
María F Lopez-Fernandez
Vicente Vicente
Consuelo González-Manchón
José Rivera
María L Lozano
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2014
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-014-0213-6

Other articles of this Issue 1/2014

Orphanet Journal of Rare Diseases 1/2014 Go to the issue